Drug Shortage Report for KENALOG-40 INJECTION

Last updated on 2025-04-17 History
Report ID 255147
Drug Identification Number 01999869
Brand name KENALOG-40 INJECTION
Common or Proper name Triamcinolone Acetonide
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 5ML & 1ML
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-04-16
Actual start date 2025-04-16
Estimated end date 2025-07-07
Actual end date
Shortage status Actual shortage
Updated date 2025-04-17
Company comments The shortages are for both 5ML and 1 ML.
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2025-04-17 English Compare
v4 2025-04-16 French Compare
v3 2025-04-16 English Compare
v2 2025-04-16 French Compare
v1 2025-04-16 English Compare

Showing 1 to 5 of 5